Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of FLT3-ITD in NPM1 Mutated AML, Irrespectively of FLT3-ITD Allelic Burden
暂无分享,去创建一个
M. Gobbi | R. Fanin | N. Colombo | M. Miglino | M. Cea | M. Bocchia | A. Candoni | P. Minetto | F. Guolo | R. Lemoli | A. Sicuranza | M. Clavio | M. Zannier | Maria Vittoria Dubbini | F. Ballerini | S. Ciofini | Riccardo Marcolin | E. Carminati | Adele Santoni | G. Pugliese | Luca Lanino